NEW DELHI — The Indian Council of Medical Research (ICMR) has rejected a recent study led by Banaras Hindu University (BHU), which claimed that Covaxin...

HYDERABAD — Bharat Biotech on Thursday said that its Covid-19 vaccine Covaxin has an excellent safety record without any vaccine-associated incidents of blood clots, thrombocytopenia,...

New Delhi, Feb. 3 (PTI): An ICMR study has indicated that a booster dose of Covaxin is safe and necessary to ensure persistent immunity to...

New Delhi, Jan. 7 (PTI): Neutralising antibody responses against the SARS-COV-2 virus and its variants of concern (VoC) are higher among Covishield recipients than those...

Our Reporter Dimapur, Feb. 21 (EMN): A total of 68,279 doses of Covaxin — 56,227 (39.59%) first dose and 12,052 (8.49%) second dose — have...

New Delhi, Jan. 27 (PTI): India’s drug regulator has granted regular market approval for Covid-19 vaccines Covishield and Covaxin for use in the adult population...

Our Correspondent/ Reporter Kohima/ Dimapur, Jan. 4 (EMN): As many as 225 doses of Covaxin were administered in Nagaland on the first day of the...

Our Correspondent Kohima, Jan. 4 (EMN): As many as 225 doses of Covaxin were administered in Nagaland on the first day of the Covid vaccination...

United Nations/Geneva, Oct. 18 (PTI): The WHO’s technical advisory group will meet on October 26 to consider the emergency use listing of India’s Covaxin which...

New Delhi, Oct. 12 (PTI): An expert panel of India’s Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech’s Covaxin for children...